New drug candidates identified in bacteria
-
- It is mainly known about cyanobacteria that they carry out photosynthesis like plants. However, this group of bacteria also produces many interesting natural products, including the newly discovered lipopeptides. (Photograph: Adobe Stock)
Bacteria show great promise as a source of active ingredients. Using computer-based genome analysis, researchers at ETH Zurich have now discovered a new class of natural products that might one day serve as antibiotics.
Animals, plants, fungi and bacteria – each and every organism carries a whole armoury of chemical compounds that enable it to interact with its environment, attract partners or deter enemies. Bacteria, among the oldest forms of life on earth, contain a host of complex chemical structures, accumulated over millions of years of evolution.
Many of these metabolites have proved highly effective as active ingredients in human medicine. Indeed, around one-third of the medicinal drugs approved today are derived from natural products. This includes most antibiotics.
Unlocking the chemical mysteries of bacteria is, however, not all that easy. The snag is that many types of bacteria are difficult, if not impossible, to cultivate in the laboratory. And, frequently, it is only in tandem with other organisms that they produce natural products that are of interest to medicine.
The application of bioinformatics and modern DNA sequencing methods can significantly expedite the hunt for new active ingredients. Using this approach, a research team led by Jörn Piel, Professor of Microbial Interactions at ETH Zurich, has now discovered a new synthetic pathway for peptide natural products that appears to be widespread in bacteria.
The present study describes a total of three enzymes that attach fatty acids of differing chain lengths to a peptide. “Initial experiments show that it is indeed possible to produce these customised lipopeptides in the lab,” says Anna Vagstad, another of the study’s lead authors. The next step will be to investigate the biological activity of this new substance class.
“There’s often minimal financial incentive for pharmaceutical companies to develop new antibiotics,” Vagstad says, “but we researchers can at least take the first step, which is to search for new active ingredients.”
More news
- Genetics as Conservation Tool for Endangered Chimpanzees
- When stress makes you sick
- Achieving a better understanding of how the blood-brain barrier works
- Unlocking the data treasure chest
- Artificial Intelligence Improves Efficiency of Genome Editing
- Alien plant species are spreading rapidly in mountainous areas
- From molecules to organisms
- The Oracle of Leaves
- How grasses avoid inbreeding
- New Virus Discovered in Swiss Ticks
- Protein shapes indicate Parkinson’s disease
- The seeds have germinated
- Watching the metabolism at work
- A Fountain of Youth for Blood Vessels
- In the Jungle of Neurons
- Fighting tumours with magnetic bacteria
- How genetics influences our body weight beyond the genes
- Immunotherapy Reduces Lung and Liver Fibrosis in Mice
- Preparing for future coronavirus variants using artificial intelligence
- Determining why the Arctic is turning ever greener
- Seeds for All
- First map of immune system connections reveals new therapeutic opportunities
- Global Spread of Powdery Mildew through Migration and Trade
- Resistance to mosaic disease in cassava explained
- Individual Cells Are Smarter Than Thought
- Social Development of Infants Unaffected by Covid-19 Pandemic
- Wonderful World of Wheat
- Severe flu risk as immune cells swap with age
- Dangerous Bites
- Tapping the ocean as a source of natural products
- Breast cancer spreads at night
- In the Beginning Was the Popcorn
- Diverse Forests Outyield Monocultures
- World Premiere: Successful Transplant of Human Liver Treated in Machine
- Dolphins Self-Medicate Skin Ailments at Coral “Clinics”
- Bacteria with recording function capture gut health status
- Environmental DNA reveals secret reef inhabitants
- Astrocyte Networks in the Mouse Brain Control Spatial Learning and Memory
- Like bacteria firing spearguns
- Immunological Memory Provides Long-Term Protection against Coronavirus
- “Animal experiments will remain indispensable in the foreseeable future”
- Agents between good and evil
- “We have created a stable active ingredient”
- AI offers a faster way to predict antibiotic resistance
- Evidence-Based Contribution of Mechano-Biological Descriptors of Resistance Exercise
- Mechanism for DNA Invasion of Adenoviral Covid-19 Vaccines Discovered
- Saving infants' lives with iron
- Rapid PCR tests at the touch of a button
- When Resistant Germs Travel
- When Stress Makes You Sick
- Healthy People, Healthy Animals
- We are less sceptical of genetic engineering than assumed
- Humans and Chimps
- Computer algorithms are currently revolutionising biology
- Toxicity testing on the placenta and embryo
- Courting Females
- Eating Our Way Through the Pandemic
- Optimising nature
- Luring bacteria into a trap
- A deep dive into the brain
- How tendons become stiffer and stronger
- The African Wild Dog: An Ambassador for the World’s Largest Terrestrial Conservation Area
- The Achilles heel of the Coronavirus
- A simple exterior – but complex interior
- Brain Tumors under Attack
- Planting Underpants
- How bacteria sleep through antibiotic attacks
- Synchronization of Brain Hemispheres Changes What We Hear
- Unusual mutation causes defective sperm in boars
- Detailed tumour profiling
- How a large protein complex assembles in a cell
- What immune cells reveal about sleep disorders
- Depression therapy: Adrift on the Ocean
- Which factors trigger leaf die-off in autumn?
- Medical microrobots score the Breakthrough of the Year
- Understanding mutations at different levels of the cell